Trial Profile
Molecular Biomarkers for Colorectal Liver Metastases Resectability after Chemotherapy with Cetuximab MARCATORI BIOMOLECOLARI DI RESECABILITA' PER METASTASI EPATICHE COLORETTALI TRATTATE CON CHEMIOTERAPIA PIU' CETUXIMAB
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Oct 2012
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms POCHER-2
- 11 Oct 2012 New trial record